Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG-782 and INT0133-A Report From the Children's Oncology Group Bone Tumor Committee-Reference-Cited by-同舟云学术

Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG-782 and INT0133-A Report From the Children's Oncology Group Bone Tumor Committee

Published:2016-04-29 Issue:10 Volume:63 Page:1737-1743
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Bishop Michael W.¹²,Chang Yu-Chen³,Krailo Mark D.³,Meyers Paul A.⁴,Provisor Arthur J.⁵,Schwartz Cindy L.⁶,Marina Neyssa M.⁷,Teot Lisa A.⁸,Gebhardt Mark C.⁹,Gorlick Richard¹⁰,Janeway Katherine A.¹¹,Chou Alexander J.⁴

Affiliation:

1. Department of Oncology; St. Jude Children's Research Hospital; Memphis Tennessee

2. Department of Pediatrics; University of Tennessee Health Science Center; Memphis Tennessee

3. Department of Preventive Medicine; University of Southern California; Los Angeles California

4. Department of Pediatrics; Memorial Sloan Kettering Cancer Center; New York

5. Division of Pediatric Hematology-Oncology; Children's Hospital of Memorial University Medical Center; Savannah Georgia

6. Division of Pediatrics; M.D. Anderson Cancer Center; Houston Texas

7. Department of Pediatric Hematology-Oncology; Lucile Packard Children's Hospital at Stanford; Palo Alto California

8. Department of Pathology; Boston Children's Hospital; Boston Massachusetts

9. Department of Orthopaedic Surgery; Boston Children's Hospital; Boston Massachusetts

10. Division of Pediatric Hematology/Oncology; The Children's Hospital at Montefiore; Bronx New York

11. Department of Pediatric Oncology; Dana-Farber/Boston Children's Cancer and Blood Disorders Center; Boston Massachusetts

Funder

Children's Oncology Group

National Institutes of Health

WWWW (QuadW) Foundation, Inc.

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference33 articles.

1. Osteosarcoma incidence and survival rates from 1973 to 2004: Data from the Surveillance, Epidemiology, and End Results program;Mirabello;Cancer,2009

2. Osteosarcoma: A randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate;Meyers;J Clin Oncol,2005

3. Chemotherapy for nonmetastatic osteogenic sarcoma: The Memorial Sloan-Kettering experience;Meyers;J Clin Oncol,1992

4. Osteosarcoma: The COSS experience;Bielack;Cancer Treat Res,2009

5. Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group study POG-8651;Goorin;J Clin Oncol,2003

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long term survival in adult osteosarcoma patients treated with a two-drug regimen: Final results of the OSAD93 phase II study of the FSG-GETO;European Journal of Cancer;2024-09

2. Dynamic Prediction of Overall Survival for Patients with Osteosarcoma: A Retrospective Analysis of the EURAMOS-1 Clinical Trial Data;Current Oncology;2024-06-22

3. Impact of Postoperative Radiotherapy on Survival in Primary Osteosarcoma: A population-based study;2024-06-04

4. Prognostic factors in high-grade pediatric osteosarcoma among children and young adults: Greek Nationwide Registry for Childhood Hematological Malignancies and Solid Tumors (NARECHEM-ST) data along with a systematic review and meta-analysis;Cancer Epidemiology;2024-06

5. Cell Cycle Checkpoints p16 and p21—Strong Predictors of Clinicopathologic Outcomes in High-Grade Osteosarcoma;The Cancer Journal;2024-05